compani offici indic execut shuffl
consider prior fda action
prompt mr. beisang could reach comment
50 % bioplasti $ 12.2 million sale
fiscal year end last juli 31 came breast implant
net incom fiscal 1991 $ 568,000
mr. beisang 60 second chief execut breast
implant maker step asid month dow corn corp.
fire critic earlier combat stanc
regard question implant safeti name keith r
mckennon dow chemic co. execut chief
execut offic feb. 10 succeed lawrenc reed
remain compani chief oper offic dow corn
joint ventur dow chemic corp. corn inc
bioplasti breast implant troubl start
jan. 6 fda moratorium implant sale last juli fda
seiz $ 20,000 bioplasti nonsilicon inflat
breast implant market name misti gold
regul alleg bioplasti market implant
use improp claim say implant
transpar x-ray without fda approv fda also
order bioplasti recal $ 740,000 misti
gold implant sold
earlier month bioplasti said expect
fda approv soon differ version misti gold
implant
compani also expect announc week
settlement sharehold suit aros fda
implant recal juli said bioplasti presid timothi p
lawin name succeed mr. beisang chief
execut offic compani director daniel g. holman
name chairman bioplasti
uroplasti form recent contain urolog
product busi medic equip maker
account less 1 % bioplasti sale fiscal
1991 compani said
